SKYBIOTECH HEALTHCARE LIMITED (SKYBIOTECH) reported revenue of ₹49.31 L and a net loss of ₹57.36 L for the quarter ended 2026-06-30. Figures are parsed from the company's filed results.
The statements below are read from SKYBIOTECH HEALTHCARE LIMITED’s filed results, 8 filed quarters and 3 fiscal years on record, consolidated basis. Price-linked ratios are computed at the last close, sector medians across the served universe, ownership from the shareholding pattern, and any cell whose input isn’t on record shows a dash, never an estimate.
Latest: Q1 FY26-27 · filed Aug 14, 2026
| ₹ Cr | Jun2024 | Dec2024 | Mar2025 | Jun2025 | Sep2025 | Dec2025 | Mar2026 | Jun2026Latest | YoYlatest |
|---|---|---|---|---|---|---|---|---|---|
| Sales | 2.39 | 1.92 | 1.02 | 2.39 | 2.52 | 0.96 | 1.83 | 0.49 | -79.4% |
| 2.31 | 2.02 | 2.10 | 2.31 | 2.96 | 1.41 | 2.71 | 1.02 | -56.0% | |
| Operating profit | 0.07 | -0.10 | -1.09 | 0.07 | -0.44 | -0.44 | -0.88 | -0.52 | n/m |
| OPM % | 3.1% | -5.2% | -106.6% | 3.1% | -17.5% | -46.0% | -48.1% | -106.4% | -109.5 pp |
| Other income | 0.03 | 0.04 | -0.18 | 0.03 | 0.15 | 0.08 | 0.15 | 0.06 | +75.7% |
| Interest | 0.01 | 0.11 | -0.23 | 0.01 | 0.00 | 0.00 | 0.00 | 0.00 | -47.9% |
| Depreciation | 0.12 | 0.14 | 0.15 | 0.12 | 0.12 | 0.12 | 0.12 | 0.11 | -11.4% |
| Profit before tax | -0.02 | -0.31 | -1.18 | -0.02 | -0.41 | -0.48 | -0.85 | -0.57 | n/m |
| Tax % | n/a (loss) | n/a (loss) | n/a (loss) | n/a (loss) | n/a (loss) | n/a (loss) | n/a (loss) | n/a (loss) | — |
| Net profit | -0.02 | -0.31 | -1.08 | -0.02 | -0.39 | -0.48 | -0.30 | -0.57 | n/m |
| EPS (₹) | — | — | -13.68 | — | — | -1.29 | -2.96 | -2.56 | — |
